Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1986 1
1987 3
1988 1
1989 4
1991 4
1992 5
1993 3
1994 5
1995 7
1996 6
1997 7
1998 13
1999 8
2000 6
2001 18
2002 7
2003 12
2004 13
2005 12
2006 14
2007 19
2008 10
2009 16
2010 19
2011 15
2012 29
2013 21
2014 32
2015 29
2016 23
2017 33
2018 29
2019 19
2020 26
2021 31
2022 16
2023 19
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the Inflammasome in Cardiovascular Disease.
Olsen MB, Gregersen I, Sandanger Ø, Yang K, Sokolova M, Halvorsen BE, Gullestad L, Broch K, Aukrust P, Louwe MC. Olsen MB, et al. Among authors: gullestad l. JACC Basic Transl Sci. 2021 Nov 3;7(1):84-98. doi: 10.1016/j.jacbts.2021.08.006. eCollection 2022 Jan. JACC Basic Transl Sci. 2021. PMID: 35128212 Free PMC article. Review.
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
Prapiadou S, Živković L, Thorand B, George MJ, van der Laan SW, Malik R, Herder C, Koenig W, Ueland T, Kleveland O, Aukrust P, Gullestad L, Bernhagen J, Pasterkamp G, Peters A, Hingorani AD, Rosand J, Dichgans M, Anderson CD, Georgakis MK. Prapiadou S, et al. Among authors: gullestad l. Circulation. 2024 Feb 27;149(9):669-683. doi: 10.1161/CIRCULATIONAHA.123.064974. Epub 2023 Dec 28. Circulation. 2024. PMID: 38152968 Free article.
Myocardial fibrosis.
Espeland T, Lunde IG, H Amundsen B, Gullestad L, Aakhus S. Espeland T, et al. Among authors: gullestad l. Tidsskr Nor Laegeforen. 2018 Oct 12;138(16). doi: 10.4045/tidsskr.17.1027. Print 2018 Oct 16. Tidsskr Nor Laegeforen. 2018. PMID: 30344312 Free article. Review. English, Norwegian.
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L. Broch K, et al. Among authors: gullestad l. J Am Coll Cardiol. 2021 Apr 20;77(15):1845-1855. doi: 10.1016/j.jacc.2021.02.049. J Am Coll Cardiol. 2021. PMID: 33858620 Free article. Clinical Trial.
Re: Over 80 år og hjerteinfarkt.
Tegn N, Abdelnoor M, Aaberge L, Endresen K, Gullestad L, Bendz B. Tegn N, et al. Among authors: gullestad l. Tidsskr Nor Laegeforen. 2016 Sep 13;136(16):1324-5. doi: 10.4045/tidsskr.16.0685. eCollection 2016 Sep. Tidsskr Nor Laegeforen. 2016. PMID: 27637033 Free article. Norwegian. No abstract available.
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
Abraham WT, Lindenfeld J, Ponikowski P, Agostoni P, Butler J, Desai AS, Filippatos G, Gniot J, Fu M, Gullestad L, Howlett JG, Nicholls SJ, Redon J, Schenkenberger I, Silva-Cardoso J, Störk S, Krzysztof Wranicz J, Savarese G, Brueckmann M, Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C, Salsali A, Anker SD. Abraham WT, et al. Among authors: gullestad l. Eur Heart J. 2021 Feb 11;42(6):700-710. doi: 10.1093/eurheartj/ehaa943. Eur Heart J. 2021. PMID: 33351892 Clinical Trial.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. Among authors: gullestad l. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity.
Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M. Raju SC, et al. Among authors: gullestad l. Genome Med. 2024 Feb 8;16(1):27. doi: 10.1186/s13073-024-01296-6. Genome Med. 2024. PMID: 38331891 Free PMC article. Clinical Trial.
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes.
Krämer BK, Hauske SJ, Chilton R, Mann JFE, Gullestad L, Fitchett D, Mattheus M, Steubl D, Wanner C. Krämer BK, et al. Among authors: gullestad l. J Diabetes Complications. 2023 Sep;37(9):108588. doi: 10.1016/j.jdiacomp.2023.108588. Epub 2023 Aug 17. J Diabetes Complications. 2023. PMID: 37633072 Free article. Clinical Trial.
Activated platelets and atherosclerosis.
Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K. Aukrust P, et al. Among authors: gullestad l. Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1297-307. doi: 10.1586/erc.10.92. Expert Rev Cardiovasc Ther. 2010. PMID: 20828352 Review.
493 results